Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 14/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.44 |
| ▸ | CCR4 | P51679 | 1/20 | 0.41 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23093460 | 1.00 | LRRK2 (0.48) | LRRK2PTGS2PTGS1CCR4ABCC4 | |
| SCHEMBL23093472 | 0.83 | LRRK2 (0.42) | LRRK2PTGS2PTGS1CCR4 | |
| SCHEMBL23093236 | 0.83 | FAAH (0.41) | LRRK2PTGS2PTGS1CCR4ABCC4 | |
| SCHEMBL23093139 | 0.83 | LRRK2 (0.48) | LRRK2PTGS2PTGS1CCR4 | |
| SCHEMBL23093261 | 0.81 | PTGS2 (0.47) | PTGS2PTGS1ABCC4ABCB11PDE4D | |
| SCHEMBL23093414 | 0.79 | KCNH2 (0.55) | PTGS2PTGS1 | |
| SCHEMBL23110907 | 0.77 | CCR4 (0.34) | PTGS2PTGS1CCR4MAPK14 | |
| SCHEMBL23110566 | 0.71 | MAPT (0.34) | CCR4 | |
| SCHEMBL29802440 | 0.69 | PTGS2 (0.46) | LRRK2PTGS2PTGS1CCR4 | |
| SCHEMBL23093191 | 0.69 | PTGS2 (0.42) | PTGS2PTGS1CCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4027993-A1 | CYCLOOXYGENASE-2 INHIBITORS AND USES THEREOF | The Broad Institute Inc. (US) | 2022-07-20 | — | — | EP | disclosed |